Bionano to Report Second Quarter 2025 Financial Results and Host a Conference Call Webcast on August 14, 2025
Bionano Genomics (Nasdaq: BNGO) has scheduled its second quarter 2025 financial results conference call and webcast for August 14, 2025, at 4:30 p.m. Eastern Time.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Bionano Genomics (Nasdaq: BNGO) has scheduled its second quarter 2025 financial results conference call and webcast for August 14, 2025, at 4:30 p.m. Eastern Time. The company will present its Q2 2025 financial performance and provide updates on recent corporate developments.
Investors and interested parties can access the live webcast through the company's investor relations website. A replay of the presentation will be available for at least 30 days after the event on Bionano's IR website at ir.bionano.com.
Details
News Market Reaction – BNGO
The recorded move for BNGO in the trading session of this news was -1.99%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, July 31, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Thursday, August 14, 2025, at 4:30 p.m. Eastern Time to report financial results for the second quarter 2025 and to highlight recent corporate progress.
Conference Call & Webcast Details
| Date: | Thursday, August 14th, 2025 |
| Time: | 4:30 p.m. ET |
| Participant Link: | Registration – Click here |
| Webcast Link: | https://edge.media-server.com/mmc/p/tnombut6/ |
Participants may access a live webcast of the call on the Investors page of the Bionano website. A replay of the conference call and webcast will be archived on Bionano’s investor relations website at https://ir.bionano.com/ for at least 30 days.
CONTACTS
Company Contact:
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionano.com
Investor Relations:
Kelly Gura
Gilmartin Group
+1 (212) 229-6163
IR@bionano.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.